admin – Page 5220 – Get News Story

Primary Hyperoxaluria Market Poised for Significant Growth from 2024 to 2034, Reports DelveInsight | Dicerna Pharmaceuticals, Inc., Allena Pharmaceuticals, Biocodex, Alnylam Pharmaceuticals

The Key Primary Hyperoxaluria Companies in the market include – Alnylam Pharma, Allena Pharmaceuticals, Biocodex, Biocodex, Dicerna Pharmaceuticals, and others.

DelveInsight’s “Primary Hyperoxaluria Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Primary Hyperoxaluria, historical and forecasted epidemiology as well as the Primary Hyperoxaluria market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Primary Hyperoxaluria market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Primary Hyperoxaluria Market Forecast

Some of the key facts of the Primary Hyperoxaluria Market Report:

The Primary Hyperoxaluria market size was valued approximately ~USD 316 Million in 2023 and is anticipated to grow with a significant CAGR during the study period (2020-2034)
In 2023, the United States represented the largest market for Primary Hyperoxaluria, making up about 89% of the total market size across the 7MM, compared to other major markets such as the EU4 countries (Germany, France, Italy, and Spain), the United Kingdom, and Japan.
In 2023, Germany held the largest market size for Primary Hyperoxaluria among European countries, reaching approximately USD 8 million, while Spain had the smallest market size, totaling around USD 4.3 million.
The estimated market size for Primary Hyperoxaluria in Japan was approximately USD 1.3 million in 2023.
According to DelveInsight’s assessment, the estimated total prevalent cases of Primary Hyperoxaluria across the 7MM were approximately 12,000 in 2023.
The US recorded the highest total diagnosed prevalent cases of Primary Hyperoxaluria in 2023, with approximately 2,000 cases, and these numbers are expected to increase in the future.
In 2023, the UK reported the highest number of diagnosed prevalent cases of Primary Hyperoxaluria in Europe, with approximately 220 cases, followed by Germany with around 188 cases. Spain had the lowest prevalence, with about 100 cases.
In 2023, Japan had the smallest number of diagnosed prevalent cases of Primary Hyperoxaluria, representing roughly 2.5% of the total cases across the 7MM.
In 2023, the highest number of diagnosed prevalent cases of Primary Hyperoxaluria in the US was seen in the 0–4 age group (~780 cases), followed by the 5–9 age group (~470 cases). The fewest cases were observed in the 15–19 years age group.
Key Primary Hyperoxaluria Companies: Alnylam Pharma, Allena Pharmaceuticals, Biocodex, Biocodex, Dicerna Pharmaceuticals, and others
Key Primary Hyperoxaluria Therapies: OXLUMO (Lumasiran/ALN-GO1), RIVFLOZA (nedosiran/DCR-PHXC), Nedosiran (DCR-PHXC), ALLN-177, stiripentol (Diacomit), DCR-PHXC, and others
The Primary Hyperoxaluria epidemiology based on gender analyzed that males contributes to higher diagnosed prevalent cases as compared to females
The Primary Hyperoxaluria market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Primary Hyperoxaluria pipeline products will significantly revolutionize the Primary Hyperoxaluria market dynamics.

Primary Hyperoxaluria Overview

Primary Hyperoxaluria (PH) is a rare genetic disorder characterized by the overproduction of oxalate, a substance normally found in the body that combines with calcium to form calcium oxalate. In people with PH, this process occurs excessively due to defects in specific enzymes involved in the metabolic pathways that process glyoxylate and glycolate.

Get a Free sample for the Primary Hyperoxaluria Market Report:

https://www.delveinsight.com/report-store/primary-hyperoxaluria-market

Primary Hyperoxaluria Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Primary Hyperoxaluria Epidemiology Segmentation:

The Primary Hyperoxaluria market report proffers epidemiological analysis for the study period 2020–2034 in the 7MM segmented into:

Prevalent Cases of Primary Hyperoxaluria in the 7MM
Diagnosed Prevalent Cases of Primary Hyperoxaluria in the 7MM
Gender-specific Cases of Diagnosed Prevalent Cases of Primary Hyperoxaluria in the 7MM
Age-specific Cases of Diagnosed Prevalent Cases of Primary Hyperoxaluria in the 7MM
Type-specific Cases of Diagnosed Prevalent Cases of Primary Hyperoxaluria in the 7MM

Download the report to understand which factors are driving Primary Hyperoxaluria epidemiology trends @ Primary Hyperoxaluria Epidemiology Forecast

Primary Hyperoxaluria Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Primary Hyperoxaluria market or expected to get launched during the study period. The analysis covers Primary Hyperoxaluria market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Primary Hyperoxaluria Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Primary Hyperoxaluria Therapies and Key Companies

OXLUMO (Lumasiran/ALN-GO1): Alnylam Pharma
RIVFLOZA (nedosiran/DCR-PHXC): Dicerna Pharmaceuticals, Inc.
Nedosiran (DCR-PHXC): Dicerna Pharmaceuticals, Inc.
ALLN-177: Allena Pharmaceuticals
Stiripentol: Biocodex
stiripentol (Diacomit): Biocodex
DCR-PHXC: Dicerna Pharmaceuticals

Discover more about therapies set to grab major Primary Hyperoxaluria market share @ Primary Hyperoxaluria Treatment Market

Primary Hyperoxaluria Market Strengths

The increasing prevalent population worldwide is likely to cause a surge in treatment options, and consequently, the market will witness a boost in upcoming years.
The shortfall of approved therapies might provide good space for emerging therapies in the market.

Primary Hyperoxaluria Market Opportunities

Limited approved treatment options offer a great opportunity for the investment and development of novel therapies
Medications with better safety and effectiveness, which provide an optimum cure, are the current unmet need of the primary hyperoxaluria disease market.

Scope of the Primary Hyperoxaluria Market Report

Study Period: 2020–2034
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
Key Primary Hyperoxaluria Companies: Alnylam Pharma, Allena Pharmaceuticals, Biocodex, Biocodex, Dicerna Pharmaceuticals, and others
Key Primary Hyperoxaluria Therapies: OXLUMO (Lumasiran/ALN-GO1), RIVFLOZA (nedosiran/DCR-PHXC), Nedosiran (DCR-PHXC), ALLN-177, stiripentol (Diacomit), DCR-PHXC, and others
Primary Hyperoxaluria Therapeutic Assessment: Primary Hyperoxaluria current marketed and Primary Hyperoxaluria emerging therapies
Primary Hyperoxaluria Market Dynamics: Primary Hyperoxaluria market drivers and Primary Hyperoxaluria market barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Primary Hyperoxaluria Unmet Needs, KOL’s views, Analyst’s views, Primary Hyperoxaluria Market Access and Reimbursement

To know more about Primary Hyperoxaluria companies working in the treatment market, visit @ Primary Hyperoxaluria Clinical Trials and Therapeutic Assessment

Table of Contents

1. Primary Hyperoxaluria Market Report Introduction

2. Executive Summary for Primary Hyperoxaluria

3. SWOT analysis of Primary Hyperoxaluria

4. Primary Hyperoxaluria Patient Share (%) Overview at a Glance

5. Primary Hyperoxaluria Market Overview at a Glance

6. Primary Hyperoxaluria Disease Background and Overview

7. Primary Hyperoxaluria Epidemiology and Patient Population

8. Country-Specific Patient Population of Primary Hyperoxaluria

9. Primary Hyperoxaluria Current Treatment and Medical Practices

10. Primary Hyperoxaluria Unmet Needs

11. Primary Hyperoxaluria Emerging Therapies

12. Primary Hyperoxaluria Market Outlook

13. Country-Wise Primary Hyperoxaluria Market Analysis (2020–2034)

14. Primary Hyperoxaluria Market Access and Reimbursement of Therapies

15. Primary Hyperoxaluria Market Drivers

16. Primary Hyperoxaluria Market Barriers

17. Primary Hyperoxaluria Appendix

18. Primary Hyperoxaluria Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Primary Hyperoxaluria Market Poised for Significant Growth from 2024 to 2034, Reports DelveInsight | Dicerna Pharmaceuticals, Inc., Allena Pharmaceuticals, Biocodex, Alnylam Pharmaceuticals

5-day Countdown: Brands at Home and Abroad to Gather at Interfiliere Shanghai 2024

About Interfiliere Shanghai 2024

The 20th edition of Interfiliere Shanghai will be held at the Shanghai Exhibition Center from October 15 to 16, 2024. Covering an area of 12,000 square meters, the exhibition will feature nearly 170 participating companies and is expected to attract approximately 5,000 professional visitors.

Interfiliere Shanghai 2024 is to be featured with a number of campaigns, such as 2026 spring and summer vogue trends, prototype fashion shows, green planet, renowned university-industry cooperation, COLORO-Yuancai cooperation, Interfeel ‘AWARDS ceremony, high-quality meetings and forums, business and trade matchmaking meetings, Interfiliere Shanghai× Sportsinnov. Club Private Sharing, Interfiliere Shanghai’s 20th Anniversary Cocktail Club, and various trend releases. In addition, more than 10 industry big names are to talk about hot topics in the underwear fashion industry. Well-known underwear brands, sportswear brands, swimwear brands, home clothing brands, etc. both at home and abroad are to be integrated into one of the main target markets for Interfiliere Shanghai by virtue of the concept of underwear fashion in a broad sense to expand the scope of buyers so as to achieve the purpose of expanding market channels and enhance the effect of Interfiliere Shanghai as an exhibition event. In the meantime, business development will be accelerated by creating exhibition scenes to help enterprises enhance the influence of their brands in the market both in China and abroad.

PART 1 Leading Underwear Brands from Around the World Are Here!

As a grand industry event featured with big name gathering and professional innovation, Interfiliere Shanghai is committed to setting up an influential platform for communications in the industry by virtue of its strength. For professionals, both the upstream and downstream core resources along the industrial chain are available while cutting-edge information about various brands are easy to get. This fall, an “underwear brand fever” is sure to set off in East China!

List of International Branded Buyers

List of Domestic Branded Buyers

In no particular order.

Well-known brands both in China and abroad are getting together. Get registered in advance now, no need to pay 49.9 yuan for a ticket on the spot! Otherwise, people will have to wait for such a gathering for a whole year!

Keep pressing down for the code, a ticket to pay a visit to the ceremony for celebrating the 20th anniversary of Interfiliiere Shanghai can be granted.

PART 02

Eleven highlights on the scene have been shown

To have all the needs of the audience satisfied and have the exhibitors’ needs seamlessly met.

Highlight 1: High-Quality Conferences & Forums

Highlight 2: Product Displays by Leading Exhibitors

The above pictures above are all data on the previous sessions, which are just used for reference here.

Highlight 3: Trend Forum – 2026 Spring/Summer Fashion Trends Release

The release of trends in the summer of 2026 is to mark the key moment for the evolution and development of underwear, body sculpting underwear, sports fabrics and accessories.

As predicted by Concepts of Paris, the world’s top trend agency, the focus in the summer of 2026 will shift from a trend-oriented display to a new method centered on nine active moments. Such a change would highlight that in this society, the time of active “me” would become an important factor to offset the hardships and uncertainty in the world around all.

Past Trend Releases of Interfilière SHANGHAI

Highlight 4: Prototype Fashion Show

This year, Ms. Jos Berry,the founder and creative director of Paris Concepts,is to select fabrics out of those from the exhibitors and design prototype clothes in person at Trend FORUM by combining with the nine themes of this year’s vogue trends.

And such prototypes are to be produced and manufactured by participating contract manufacturers after making patterns.

Past Sample Fashion Shows of Interfilière SHANGHAI

Number of prototype clothes: There are 9 sets in total (in accordance with the nine themes).

Time: 13: 30-14: 00, October 15-16, 2024

Booth number: 1C31

Highlight 5: Display of Graduation Design by Graduates from Donghua University & Hong Kong Polytechnic University

Graduation design works from Donghua University displayed on previous sessions

Graduation design works from Hong Kong Polytechnic University displayed on previous sessions

Highlight 6: Green Planet: La Federation Sustainable Development Trends to Be Released

In the new era, the topic of green and environmental protection has been hotly discussed year after year; and it is also a process in which the entire fabrics and auxiliary materials industry has been upgrading and conducting transformation continuously.The Austrian Lenzing Group, the world’s well-known leading cellulose fiber enterprise, and Alibaba’s new manufacturing platform “Xiniu Intelligent Manufacturing” are to jointly join hands with Interfiliere Shanghai 2024 to have the “Green Planet” environmental protection zone upgraded once again.

Highlight 7: Interfiliere×Coloro Yuancai Cooperation

Interfiliere Sunghai will join hands with Coloro Yuancai and Paris Concepts to launch the totally new INTERFILIERE SHANGHAI COLOUR CARD S/S 2026 pantone (Limited edition). There will only 800 pantones; first come, first get.

Highlight 8: Interfeel’ Awards: A Grand underwear Fashion Award Ceremony

Thanks to the diversification of consumer demands, clothing fabrics are faced with more challenges. The internationally recognized INTERFEE AWARDS ceremony is to be held at the Interfiliere Shanghai 2024 exhibition site, hence presenting the infinite charms of Asian manufacturing.

Excellent brand product series and wonderful “blackbox technologies”, which have been selected out round after round, will be presented at Interfeel Award as an international award ceremony respected by experts in the underwear, swimwear, and sportswear industries, thus it is to bring cutting-edge frontier messages to the audience.

On-site Photos from Previous INTERFEEL’AWARDS

Highlight 9: 20th Interfiliere Shanghai Commercial & Trade Matchmaking Conference

As Interfiliere Shanghai is one of the Interfiliere Global Series, a large number of domestic and foreign branded companies tend to come to Interfiliere Shanghai exhibitions every year. The offline docking demands at the exhibition will be far greater than online, especially for European and American companies. It is an excellent way to dock suppliers.

During Interfilier Shanghai 2024, two commercial and trade matching meetings are to be started at the exhibition site as required by purchasing agents of overseas brands.

Time: 1 pm to 3pm on October 15;

10 am to 12 am on October 16.

Contact: Miss Cai & Mr. Zhu

(The matchmaking meetings are to be attended only by exhibitors of the Interfiliere Shanghai 2024.)

Highlight 10: Interfiliere Shanghai×Sportsinnov. Club (SpinC) Private Club

On October 16, let’s get together at the Interfilière Shanghai 2024. The exhibition brings together the world’s top personal fashion industrial resources, specially designed for the pursuit of personal clothing with extreme comfort and high performance.

Not only a feast of vision and inspiration but also an excellent opportunity for future sports fashion pulse! Interfiliere and Sportsinnov. Club (SpinC) will jointly invite more than 20 sports brands and research and development directors to communicate with the three major brands on the spot

Guests to be present at the private club:

Meng Zhao, the person taking charge of AMIER R&D and R&D & Technology Center

Guan Xingxing, the persontaking charge of the retail operation platform and the e -commerce center of AMIER

Sarah Han, Her Senses Owner-Principal and creative director

Jay Zhang (Zhang Wenjie), Le Monde Private Brand Owner-Principal

Past Private Events of Interfilière SHANGHAI

Highlights 11: Interfiliere Shanghai 20th Anniversary Cocktail Party

Time: 18: 00-20:00 on October 15, 2024

Location: East and West Platforms Floor 2 Shanghai Exhibition Center

Attendees to be Invited: Designated guests are to be invited.

Interfiliere Shanghai 2024 exhibition appointment has started now!

Frontier trend messages, unlimited creativity and business opportunities are exhausted!

October 15-16, 2024

Shanghai Exhibition Center

Looking forward to all arrivals

The audience is pre-boarding entrance

About Interfiliere Shanghai 2024

Interfiliere Shanghai 2024 will be held at the Shanghai Exhibition Center on October 15-16, 2024. It is affiliated to the third largest exhibition group in the world. Back books have held Interfiliere Global Series Exhibitions in Paris, New York, Hong Kong and other places. It is a high-end “small and beautiful” facial auxiliary material and brand exhibition that has attracted much attention and recognition in the industry. https://interfiliere-shanghai.cn/

Media Contact
Company Name: INTERFILIERE Shanghai 2024
Contact Person: Stephen Jin
Email: Send Email
Phone: 18501676870
City: Shanghai
Country: China
Website: www.interfiliereshanghai.com

EPAC Environmental Services: Enhancing Remediation Systems for Optimal Environmental Impact

As environmental contamination concerns rise, especially in the destructive wake of Hurricane Helene, EPAC Environmental Services is stepping forward to help Florida businesses take stock. The premier environmental consulting firm with over thirty years of experience highlighted its commitment to continually enhancing and improving remediation systems to clean up Florida’s air, water, and soil.

“Environmental consulting demands not only expertise but also a forward-thinking approach to address the ever-evolving challenges our planet faces,” says the Principal and CEO at EPAC. “We’re constantly enhancing our remediation processes to best serve Florida and our clients. Whether it’s Phase I or II Environmental Assessments or natural disaster remediation, we’re in your corner.”

As a foremost provider in its field, EPAC prides itself on delivering a wide array of solutions to confront the complexities of environmental challenges. The expertise of EPAC spans a complete range of environmental management needs, from conducting mold and asbestos inspections to undertaking remedial investigations and feasibility studies.

Innovative Approaches

EPAC is committed to staying on the cusp of innovation. They keep up with the latest innovations in remediation and beyond, collaborating closely with clients to customize remediation plans in a timely, cost-effective manner. “Our clients rely on our services; you can’t hesitate with contamination issues,” explains EPAC’s Principal. “We continually evaluate new and emerging technologies, staying at the forefront of the industry to help clients achieve optimal results.”

EPAC’s seasoned consultants and engineers ensure that their services don’t just comply with regulations – they exceed their requirements. “At EPAC, it’s not just about completing a project. We want to make a lasting, positive impact on our environment.

With an enduring commitment to environmental stewardship and regulatory compliance, EPAC has carved a niche in the market, specializing in services ranging from Phase I and II Environmental Site Assessments to contamination sampling and asbestos surveys.

Sustainability in All Things

EPAC’s commitment to leaving a positive impact on the environment goes beyond individual projects. The company is dedicated to sustainable best practices to reduce their ecological footprint, through responsible waste disposal, using environmentally friendly products, sourcing sustainably, and efficient energy usage.

“We’re not just here to help — we’re here to set an example,” affirms EPAC’s Principal. “We practice what we teach, showing data-driven results to help clients make responsible choices for their projects.”

About EPAC Environmental Services

Founded in 1987, EPAC rapidly established itself as a leader in environmental consulting and engineering. From its initial focus on Phase I and II Environmental Site Assessments, EPAC has significantly expanded services to meet the evolving needs of Florida properties. Services now include fuel polishing, tank installation, removal and repairs, Broward Co. Surface Water Management License Renewals, contamination sampling, asbestos surveys, and NEPA checklist reviews, among others.

EPAC ensures high-quality service that meets clients’ specific requirements within strict timelines and budgets. This dedication to excellence has fostered lasting partnerships and a significant portion of repeat business. Whether for government, commercial, or individual projects, EPAC’s expertise encompasses the full spectrum of environmental management, positioned to lead with innovative and sustainable solutions for today’s environmental challenges.

For expert guidance on environmental assessments to complex remediation efforts, EPAC Environmental Services Inc. stands ready with the experience and expertise necessary to drive successful project outcomes. Interested parties can contact EPAC’s offices to discover how their specialists can address environmental needs and contribute towards a cleaner, more sustainable future.

Media Contact
Company Name: EPAC Environmental Services, Inc.
Email: Send Email
Phone: (954) 974-7055
City: Pompano Beach
State: Florida
Country: United States
Website: https://www.epacinc.com/

Primary Biliary Cholangitis Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Intercept Pharma, Enanta Pharma, COUR Pharma, Novartis, Gannex Pharma, Nanjing Chia-tai

The Key Primary Biliary Cholangitis Companies in the market include – CymaBay Therapeutics, Inc., Zydus Therapeutics Inc., Gannex Pharma Co., Ltd., Genfit, CymaBay Therapeutics, Inc., Calliditas Therapeutics, HighTide Biopharma Pty Ltd, Albireo, Curome Biosciences, Tobira Therapeutics, Inc., Pliant Therapeutics, Inc., Biotie Therapies Corp., and others.

DelveInsight’s “Primary Biliary Cholangitis Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Primary Biliary Cholangitis, historical and forecasted epidemiology as well as the Primary Biliary Cholangitis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Primary Biliary Cholangitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Primary Biliary Cholangitis Market Forecast

Some of the key facts of the Primary Biliary Cholangitis Market Report:

The Primary Biliary Cholangitis market size was approximately ~USD 1,150 million in 2023 and is anticipated to grow with a significant CAGR during the study period (2020-2034)
In September 2024, Ipsen received conditional approval from the European Commission for Iqirvo® (elafibranor) 80 mg tablets, a treatment for primary biliary cholangitis (PBC) in adults who either do not respond well to ursodeoxycholic acid (UDCA) or cannot tolerate it. Iqirvo is a first-in-class oral peroxisome proliferator-activated receptor (PPAR) agonist that targets PPARα and PPARδ, which are thought to play key roles in regulating bile acid, inflammation, and fibrosis.
In August 2024, The FDA granted accelerated approval for Livdelzi® (seladelpar) for the treatment of primary biliary cholangitis (PBC). Livdelzi can be used alongside ursodeoxycholic acid (UDCA) in adults who do not respond adequately to UDCA, or as a monotherapy for those who are intolerant to UDCA. It is not recommended for patients with decompensated cirrhosis.
According to our analysis, the US reported the highest number of diagnosed prevalent cases of PBC in 2023, and these cases are anticipated to grow at a strong CAGR during the forecast period (2024–2034).
In 2023, Germany had the highest number of diagnosed prevalent cases of PBC among the EU4 countries (Germany, France, Italy, and Spain) and the United Kingdom, with approximately 34 thousand cases, and this number is expected to grow by 2034.
The incidence of PBC increases with age, peaking between 40 and 70 years. In 2023, our estimates show around 14 thousand cases in individuals under 40, with numbers rising steadily as age increases. The largest group, with 87 thousand cases, was in the 40–70 age range, while 43 thousand cases were reported in those aged 70 and above in the US.
Our analysis shows a higher prevalence of PBC in females than in males, with distribution rates of 82% for females and 18% for males in the US in 2023.
Key Primary Biliary Cholangitis Companies: CymaBay Therapeutics, Inc., Zydus Therapeutics Inc., Gannex Pharma Co., Ltd., Nanjing Chia-tai Tianqing Pharma, Intercept Pharmaceuticals, Enanta Pharmaceuticals, COUR Pharmaceutical, Novartis, Merck Sharp & Dohme LLC, Mirum Pharmaceuticals, Inc., Genfit, CymaBay Therapeutics, Inc., Calliditas Therapeutics, HighTide Biopharma Pty Ltd, Albireo, Curome Biosciences, Tobira Therapeutics, Inc., Pliant Therapeutics, Inc., Biotie Therapies Corp., and others
Key Primary Biliary Cholangitis Therapies: Seladelpar, Saroglitazar, ASC42, Obeticholic, Bezafibrate, EDP-305, CNP-104, LJN452, Emtricitabine (FTC)/Tenofovir Disoproxil (TDF), Volixibat, Elafibranor, MBX-8025, Setanaxib, HTD1801 (BUDCA), A3907, HK-660S, Cenicriviroc, PLN-74809, BTT1023, and others
The Primary Biliary Cholangitis epidemiology based on gender analyzed that Primary Biliary Cholangitis (PBC) is seen more among females than in males
The Primary Biliary Cholangitis market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Primary Biliary Cholangitis pipeline products will significantly revolutionize the Primary Biliary Cholangitis market dynamics.

Primary Biliary Cholangitis Overview

Primary Biliary Cholangitis (PBC), previously known as Primary Biliary Cirrhosis, is a chronic autoimmune liver disease that primarily affects the small bile ducts within the liver. Over time, these ducts become damaged and inflamed, leading to the buildup of bile (a digestive fluid) in the liver, which can subsequently cause liver damage and scarring (cirrhosis).

Get a Free sample for the Primary Biliary Cholangitis Market Forecast, Size & Share Analysis Report:

https://www.delveinsight.com/report-store/primary-biliary-cholongitis-pbc-market

Primary Biliary Cholangitis Epidemiology

Primary Biliary Cholangitis Epidemiology Segmentation:

The Primary Biliary Cholangitis market report proffers epidemiological analysis for the study period 2020–2034 in the 7MM segmented into:

Total Prevalence of Primary Biliary Cholangitis
Prevalent Cases of Primary Biliary Cholangitis by severity
Gender-specific Prevalence of Primary Biliary Cholangitis
Diagnosed Cases of Episodic and Chronic Primary Biliary Cholangitis

Download the report to understand which factors are driving Primary Biliary Cholangitis epidemiology trends @ Primary Biliary Cholangitis Epidemiology Forecast

Primary Biliary Cholangitis Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Primary Biliary Cholangitis market or expected to get launched during the study period. The analysis covers Primary Biliary Cholangitis market uptake by drugs, patient uptake by therapies, and sales of each drug.

The report also covers the Primary Biliary Cholangitis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Primary Biliary Cholangitis Therapies and Key Companies

Seladelpar: CymaBay Therapeutics, Inc.
Saroglitazar: Zydus Therapeutics Inc.
ASC42: Gannex Pharma Co., Ltd.
Obeticholic: Nanjing Chia-tai Tianqing Pharma
Bezafibrate: Intercept Pharmaceuticals
EDP-305: Enanta Pharmaceuticals
CNP-104: COUR Pharmaceutical
LJN452: Novartis
Emtricitabine (FTC)/Tenofovir Disoproxil (TDF): Merck Sharp & Dohme LLC
Volixibat: Mirum Pharmaceuticals, Inc.
Elafibranor: Genfit
MBX-8025: CymaBay Therapeutics, Inc.
Setanaxib: Calliditas Therapeutics
HTD1801 (BUDCA): HighTide Biopharma Pty Ltd
A3907: Albireo
HK-660S: Curome Biosciences
Cenicriviroc: Tobira Therapeutics, Inc.
Volixibat: Mirum Pharmaceuticals
PLN-74809: Pliant Therapeutics, Inc.
BTT1023: Biotie Therapies Corp.

Discover more about therapies set to grab major Primary Biliary Cholangitis market share @ Primary Biliary Cholangitis Treatment Landscape

Primary Biliary Cholangitis Market Drivers

The rise in prevalence of PBC with an increase in IBD cases, geriatric population, increase in elderly age group, and advancement in diagnostic technology such as ERCP and MBCP
Research and development are increasing the demand for better diagnosis and treatment options for Primary Biliary Cholangitis

Primary Biliary Cholangitis Market Barriers

As there is only one approved treatment for UDCAresistant Primary Biliary Cholangitis, the first drug approved in the pipeline will have a significant advantage over the others
The development of potential biomarkers such as miRNA for the diagnosis of Primary Biliary Cholangitis may improve the screening of Primary Biliary Cholangitis patients

Scope of the Primary Biliary Cholangitis Market Report

Study Period: 2020–2034
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
Key Primary Biliary Cholangitis Companies: CymaBay Therapeutics, Inc., Zydus Therapeutics Inc., Gannex Pharma Co., Ltd., Nanjing Chia-tai Tianqing Pharma, Intercept Pharmaceuticals, Enanta Pharmaceuticals, COUR Pharmaceutical, Novartis, Merck Sharp & Dohme LLC, Mirum Pharmaceuticals, Inc., Genfit, CymaBay Therapeutics, Inc., Calliditas Therapeutics, HighTide Biopharma Pty Ltd, Albireo, Curome Biosciences, Tobira Therapeutics, Inc., Pliant Therapeutics, Inc., Biotie Therapies Corp., and others
Key Primary Biliary Cholangitis Therapies: Seladelpar, Saroglitazar, ASC42, Obeticholic, Bezafibrate, EDP-305, CNP-104, LJN452, Emtricitabine (FTC)/Tenofovir Disoproxil (TDF), Volixibat, Elafibranor, MBX-8025, Setanaxib, HTD1801 (BUDCA), A3907, HK-660S, Cenicriviroc, PLN-74809, BTT1023, and others
Primary Biliary Cholangitis Therapeutic Assessment: Primary Biliary Cholangitis current marketed and Primary Biliary Cholangitis emerging therapies
Primary Biliary Cholangitis Market Dynamics: Primary Biliary Cholangitis market drivers and Primary Biliary Cholangitis market barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Primary Biliary Cholangitis Unmet Needs, KOL’s views, Analyst’s views, Primary Biliary Cholangitis Market Access and Reimbursement

To know more about Primary Biliary Cholangitis companies working in the treatment market, visit @ Primary Biliary Cholangitis Clinical Trials and Therapeutic Assessment

Table of Contents

1. Primary Biliary Cholangitis Market Report Introduction

2. Executive Summary for Primary Biliary Cholangitis

3. SWOT analysis of Primary Biliary Cholangitis

4. Primary Biliary Cholangitis Patient Share (%) Overview at a Glance

5. Primary Biliary Cholangitis Market Overview at a Glance

6. Primary Biliary Cholangitis Disease Background and Overview

7. Primary Biliary Cholangitis Epidemiology and Patient Population

8. Country-Specific Patient Population of Primary Biliary Cholangitis

9. Primary Biliary Cholangitis Current Treatment and Medical Practices

10. Primary Biliary Cholangitis Unmet Needs

11. Primary Biliary Cholangitis Emerging Therapies

12. Primary Biliary Cholangitis Market Outlook

13. Country-Wise Primary Biliary Cholangitis Market Analysis (2020–2034)

14. Primary Biliary Cholangitis Market Access and Reimbursement of Therapies

15. Primary Biliary Cholangitis Market Drivers

16. Primary Biliary Cholangitis Market Barriers

17. Primary Biliary Cholangitis Appendix

18. Primary Biliary Cholangitis Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Primary Biliary Cholangitis Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Intercept Pharma, Enanta Pharma, COUR Pharma, Novartis, Gannex Pharma, Nanjing Chia-tai

KOSPET Unveils Tough Yet Stylish X2 Series and S2 Series Wearables, Built for Adventure and Everyday Elegance available from October 10th

Shenzhen, China – October 10, 2024 – KOSPET, a leader in rugged wearable technology, proudly announces the release of two new models—the X2 series and S2 series—designed to deliver toughness, style, and advanced features for the most demanding users. Available starting October 10, 2024, these rugged wearables combine durability with functionality to meet the needs of both adventurers and active women.

The X2 Series: Premium Durability Meets Versatile Functionality

The X2 series includes the X2 Ultra and X2, both sharing a sleek, modern aesthetic that complements any outfit, whether on a hike or at the office. Both models have passed 15 military standard tests and earned an IP69K certification, the highest standard for water and dust resistance, ensuring they can withstand the rigors of outdoor adventures while maintaining a stylish appearance.

Enhanced Durability and Vibrant Display for Engaging Interaction

The X2 series features a vibrant 1.64″ AMOLED display protected by third-gen Corning Gorilla Glass, bringing your data to life with vivid colors and sharp details while ensuring enhanced durability against scratches and impacts.

Stainless Steel Craftsmanship for Enduring Strength

Crafted with a durable stainless steel case, the X2 Ultra combines elegance and toughness, making it suitable for both rugged environments and everyday wear.

Built-in GPS for Confident Navigation

Equipped with built-in GPS functionality, the X2 Ultra allows for precise outdoor tracking, enabling users to navigate with confidence during their adventures.

Extended Battery Life for All-Day Use

With up to 12 days on a single charge, the X2 Ultra and X2 is designed for extended use, making it perfect for those who need reliable performance without frequent charging.

The S2 Series: A Rugged Watch Tailored for Women

Two-Tone Look, Multi-Layered Glamour.

Specifically crafted for women, the KOSPET S2 features a two-tone color design that combines sophisticated hues with a durable, wear-resistant TPU silicone body, ensuring a fashionable yet rugged appearance. Available in Violet Pink, Lily White, Iris Green, and Strawflower Black, the S2 reflects the unique style of its wearer while providing comfort through its soft, breathable, and ultra-flexible silicone strap for all-day wear.

All-round Health Guardian

The KOSPET TANK S2 is your all-round health guardian, featuring the VP60A2 bio-tracking optical sensor and a Fresnel lens to ensure accurate health tracking across various skin tones while minimizing signal interference from arm movement. With one tap, you can measure heart rate, blood oxygen, and stress levels, and enjoy 24/7 blood pressure monitoring for your cardiovascular health.

Menstrual and Sleep Monitoring

The device provides timely predictions for menstrual, fertile, and safe periods through an intuitive monthly calendar view in the KOSPET FIT App. It also tracks your sleep stages, including deep sleep, light sleep, and REM, helping you set sleep goals and monitor short naps. For emergencies, the SOS feature allows you to alert your emergency contact quickly by pressing and holding the SEL button for three seconds.

Durability and Protection for Everyday Life

The S2 passes 15 military standard tests and earns the IP69K certification, the highest standard for water, dust, and impact resistance. With up to 12 days of battery life, the S2 series is designed for active lifestyles.

Pricing and Availability

The X2 Ultra is available for a promotional price of $119.99 (originally $149.99), while the X2 is priced at $99.99 (originally $129.99). The S2 is offered at $119.99 (originally $149.99). These promotional prices will be available for one month only, starting October 10th, 2024, through our official website and official TikTok shop.

About KOSPET

KOSPET is a leading player in rugged outdoor smartwatches with military-grade toughness. We envision the promising future of smart wearables, leverage advanced technologies to craft smart devices that benefit our everyday lives, outdoor sports and explorations. From the first-ever 4G Android smartwatch released by KOSPET, to the industry-first rugged smart band and rugged smartwatch for women, every single piece of KOSPET’s ever-refined product is the embodiment of our relentless efforts in incorporating leading hardware technology.

For more information please visit www.kospet.com

Media Contact
Company Name: KOSPET
Contact Person: Damien Sun
Email: Send Email
Country: China
Website: https://kospet.com

Funeral Home in Houston: Claire Brothers Stands Out for Reliable and Compassionate Funeral Services

Claire Brothers Funeral Home in Houston provides personalized, compassionate funeral services, blending modern facilities with decades of expertise to honor loved ones with dignity.

Claire Brothers Funeral Homehas earned a distinguished reputation for delivering compassionate, personalized funeral services to families in their time of need. With decades of experience, it provides comprehensive services that include traditional funerals, memorial services, cremations, and pre-planning options.

The funeral home in Houston boasts well-maintained chapels, reception areas, and private family rooms, offering a serene environment where loved ones can unite to honor those who have passed. It also seamlessly blends modern facilities with traditional values, offering live-streaming services so that family members and friends who cannot attend in person can still participate remotely.

A dedicated team handles every aspect of the funeral process with care, respect, and sensitivity, allowing families to honor their loved ones in dignified remembrance. From selecting flowers, personalized memorial folders, urns, and keepsakes to curating music, readings, and photo displays, the team is dedicated to helping families create a service that is as unique as the individual being remembered.

In a city as diverse as Houston, cultural sensitivity is a factor in providing funeral services that honor cultural and religious traditions. From Christian, Jewish, Muslim, and Hindu to non-religious services, the staff at Claire Brothers Funeral Home accommodates the needs and rituals of each faith and community, making it the preferred choice for families from various backgrounds.

For those seeking a customary farewell, the funeral home offers traditional services, including a viewing, funeral service, and burial. These ceremonies are conducted in state-of-the-art facilities, ensuring a respectful and dignified environment for loved ones to gather and remember.

For more information, visit https://www.clairebrothersfuneral.com/

For families preferring cremation, comprehensive services are available, including the option of holding memorial services. Cremation, whether chosen for personal, religious, or financial reasons, is handled with the utmost care, with the funeral home offering guidance on how to incorporate meaningful rituals and commemorations.

What sets Claire Brothers Funeral Home apart is its unwavering commitment to personalizing each service. Every family has a different story, and the staff works diligently to ensure that each funeral reflects the life and legacy of the departed. Prioritizing compassion and respect, this establishment has positioned itself as a leading local funeral services industry.

With a mission of providing affordable yet high-quality funeral or cremation services, Claire Brothers Funeral Home assists families with services that include filing for life insurance benefits, social security benefits, prearranging funeral services, grief counseling, monuments, and headstones.

In addition, pre-planning services can be arranged by completing an online form, allowing individuals to pre-plan their funerals in advance. This service provides peace of mind to families, knowing their loved one’s final wishes will be fulfilled as desired. Pre-planning also alleviates the financial burden families often face during the grieving process.

Despite modern advancements, the funeral home remains steadfast in upholding the traditional values of respect, dignity, and compassion. This balance of innovation and tradition has contributed to its long-standing reputation as a trusted funeral home in Houston, attesting to why families in Houston have consistently turned to this trusted funeral home to honor the passing of their loved ones.

Claire Brothers Funeral Home in Houston stands out for its outstanding and comprehensive service offerings, combining personalized care, modern facilities, and a dedication to cultural sensitivity. Its mission to provide affordable, high-quality funeral services makes it a trusted partner for grieving families seeking a compassionate funeral home in Houston offering traditional and modern services.

About the Company:

Claire Brothers Funeral Home in Houston offers compassionate and personalized funeral services, ensuring dignified farewells for loved ones. With decades of experience, the funeral home provides comprehensive services, including traditional funerals, cremations, memorial services, and pre-planning options. Known for its attention to detail, the funeral home tailors each service to reflect the unique life and legacy of the departed. Its modern facilities, cultural sensitivity, and grief support services make it a trusted choice for families seeking a respectful, caring funeral home in Houston. Claire Brothers continues to uphold its commitment to excellence and compassion.

Media Contact
Company Name: Claire Brothers Funeral Home
Contact Person: Phillip Vazquez
Email: Send Email
Phone: 1-713-271-7250
Address:7901 Hillcroft St
City: Houston
State: TX 77081
Country: United States
Website: https://www.clairebrothersfuneral.com/

Direct Primary Care Portland: PridePoint Health Delivers Comprehensive Healthcare with Personal Touch

PridePoint Health revolutionizes healthcare in Portland with its Direct Primary Care model, offering affordable, personalized medical services, and convenient physician access.

PridePoint Health, a premier provider of Direct Primary Care Portland, is transforming the healthcare landscape by offering patients affordable, accessible, and personalized medical services. With a commitment to redefining how primary care is delivered, the clinic stands out by focusing on patient-centered care, offering full-spectrum primary care to communities from diverse backgrounds.

Direct Primary Care (DPC) is a model of healthcare that prioritizes direct relationships between patients and physicians without the interference of insurance companies. This innovative approach allows patients to pay a monthly fee, often more affordable than traditional healthcare plans, which covers all of their primary care needs. At PridePoint Health, the Direct Primary Care Portland model includes unlimited office visits, same or next-day appointments, and direct access to healthcare providers through various communication channels.

By pivoting away from the traditional insurance-driven care model that is volume-based, PridePoint Health offers a more efficient way for individuals and families to receive medical attention. This value-based model appeals to patients seeking consistent, reliable care without the unpredictable costs associated with insurance.

PridePoint Health provides many services to ensure every patient’s health and well-being. The clinic focuses on preventive care, chronic disease management, and urgent care, strongly emphasizing keeping patients healthy through routine check-ups and personalized treatment plans. From diabetes and hypertension management to annual physicals and acute illness care, the clinic ensures patients meet all their medical needs under one roof.

Patients also benefit from extended office visits, allowing them to spend as much time as necessary with their physician. This comprehensive and individualized care model ensures that each patient receives a thorough evaluation, fostering trust and better health outcomes.

Several factors set PridePoint Health apart from other healthcare providers in Portland. The clinic’s focus on personalized care, transparency, and affordability positions it as the go-to destination for DPC services.

For more information, visit https://www.pridepointhealth.com/

The DPC model at PridePoint Health offers patients an affordable alternative to the unpredictable costs of traditional healthcare. With one low monthly fee, patients receive unlimited access to care, and there are no co-pays, deductibles, or hidden fees. This transparent pricing structure makes it easier for individuals and families to budget for healthcare without worrying about unexpected costs.

PridePoint Health offers personalized, patient-centered care and prioritizes building strong relationships between physicians and patients. Unlike traditional healthcare systems that often limit the time a doctor can spend with a patient, the clinic ensures longer, more personalized visits. This approach allows physicians to get to know their patients better and provide more tailored care.

Patients of PridePoint Health enjoy direct access to their healthcare providers during office hours and after hours using digital communication channels. This direct communication allows quicker responses to health concerns and fosters continuous care, whether in person or remotely.

Additionally, the clinic’s preventive care model emphasizes the importance of regular health screenings, wellness visits, and proactive disease management. By identifying potential health issues early and providing timely interventions, PridePoint Health helps patients avoid more severe health problems in the future.

With the DPC model, PridePoint Health aims to improve the overall health of the Portland community, making high-quality healthcare more accessible. Whether managing chronic conditions or addressing urgent health concerns, the clinic offers comprehensive services that put patients first.

As DPC grows in popularity, PridePoint Health remains a top choice for those seeking affordable, personalized healthcare solutions. By combining affordability and comprehensive care, the clinic has emerged as a trusted healthcare provider committed to supporting the long-term health and well-being of residents in Portland. Its innovative approach is changing how primary care is delivered, providing a new level of accessibility and convenience for patients across the region.

About the Company:

PridePoint Health is a leading provider of Direct Primary Care in Portland, offering affordable, patient-centered healthcare without the complexities of insurance. The clinic provides comprehensive services, including preventive care, chronic disease management, and urgent care, all for a low monthly fee. Patients benefit from unlimited office visits, extended time with physicians, and direct access to healthcare providers via digital communication. By focusing on personalized care and transparent pricing, PridePoint Health is transforming the healthcare experience, ensuring patients receive the attention and treatment they need to maintain their health and well-being.

Media Contact
Company Name: PridePoint Health
Contact Person: Kyle
Email: Send Email
Phone: (503) 616-2877
Address:1827 NE 44th Ave Suite 220
City: Portland
State: OR 97213
Country: United States
Website: https://www.pridepointhealth.com/

Pages of Change: how a group of high school students are tackling legal information disparity

(Dora Chen – The Founder and President of The Justice Blueprint)

Amid rising concerns over legal awareness, a team of high school students have sparked into action. In a survey conducted by CTV news, only 33 percent of respondents answered that they have read the Canadian Charter of Rights and Freedoms. The Justice Blueprint (thejusticeblueprint.com), a youth-run federally registered non-profit, aims to tackle the legal information disparity, making the law more accessible. Founder and President Dora Chen started the organization four years ago, fueled by her passion for law.

Spearheaded by Dora Chen, the team partnered with local experts and law firms, to write “A Blueprint to Canada’s Consent Law” – a guidebook that deconstructs the law into digestible information focused on ensuring youth understand their rights. Recently, The Justice Blueprint held their “Pages of Change: Blueprint Launch” event to launch the physical version of the formerly only digitally available Blueprint.

(Copies of A Blueprint to Canada’s Consent Law)

Statistics Canada reported that, in 2022, almost 78% of police-reported intimate partner violence victims were women and girls. The team has tackled these alarming statistics one Blueprint at a time. “Knowledge is power, and that is precisely the point of our Blueprints: to give the reader the power of the law.” Dora Chen said, “But, it is important to note that it is never the victim’s fault, regardless of whether they knew about the law or not. However, I think that knowing one’s rights certainly makes it more difficult for others to manipulate or coerce them. If our Blueprint helps even one person recognize the warning signs earlier or feel less alone, then we have achieved our goal.”

The Blueprint starts by debunking different myths about consent, such as “only no means no”, explaining that, instead, the framework should be “only yes means yes”. It then goes on to explain generally about the law: the difference between common law and statutory law, and consent as stated in the Criminal Code. It provides a concise, understandable, summary on the landmark Supreme Court case of R v. Ewanchuk, a case credited for the “only yes means yes” model. The Blueprint also gives resources as to what to do if one thinks they have been assaulted, and what to do if someone else shares that they have been assaulted. The Blueprint ends with a variety of resources about consent law and hotline services.

At the launch, this was all relayed to the public, where a crowd gathered to learn more.

(Blueprint presentation at Pages of Change)

Originally the Blueprint was released digitally, but feedback from local youth shelters and women resource organizations was not what the team expected. They explained that while the blueprints themselves are very helpful, the fact that they were only available digitally meant that a lot of people, who did not own their own device, could not access them. Thus, the team began their donut fundraising tour – partnering with Krispy Kreme’s fundraising program to sell the donuts across The Justice Blueprint’s Chapters (The Bishop Strachan School, Havergal College, Upper Canada College, St. Michael’s College School, Crescent, Branksome Hall, etc.). Raising over $3000 in revenue, the team professionally printed, bound, and re-released the physical copies for shelters and youth-oriented organizations.

At the event, those organizations were invited to attend and received copies of the Blueprint, while the public was also encouraged to take one. Pathways to Education, an organization dedicated to breaking down barriers to education, The Second Chance Foundation, a women’s organization and networking group, and Eva’s Initiatives for Homeless Youth were in attendance. They each expressed their support for The Justice Blueprint’s mission and project, and their admiration for the students’ passion.

(The Justice Blueprint team and representatives from Pathway to Education. The Justice Blueprint team from left to right: VP of Events and Coordination Ava Comisarow, VP of Public Relations and Marketing Jane Atkins, Founder and President Dora Chen, Pathways to Education team, VP of Logistics and Director of Chapter Heads Rutvi Vora, and Social Media Director Liv Schneiderman)

(The Justice Blueprint team with The Second Chance Foundation)

(The Justice Blueprint team and Eva’s Initiatives for Youth representative)

The Justice Blueprint team also hosted other community organizations and student organizations at the event. They had their own booths and explained their mission and recent projects to attendees, providing a networking opportunity for attendees to learn about other pressing concerns in the community.

(The Justice Blueprint team at The Second Chance Foundation’s Booth)

Media Contact
Company Name: Globalnewsonline
Contact Person: Luayy Alkilani
Email: Send Email
Country: United States
Website: http://www.globalnewsonline.info/

New Engine for Financial Leasing: Linghu Ping Leading Industry Innovation

In the context of today’s global economic integration, financial leasing, as an innovative financial service model, is becoming a key driver for corporate transformation and upgrading, as well as promoting high-quality development of the real economy, due to its unique advantages. Through flexible financing methods, financial leasing not only effectively alleviates the financial pressure on enterprises, accelerates equipment upgrades and technological advancements, but also greatly enhances their market competitiveness and profitability, injecting strong impetus into the steady progress of the real economy. In this dynamic field, Mr. Linghu Ping, as an outstanding expert and leader in the leasing and financing industry, has set a new benchmark for the industry with his exceptional leadership and visionary strategic insight.

As the General Manager of Guizhou Yuyin Leasing Co., Ltd., Linghu Ping has led the company to achieve a leap forward in its business capabilities, thanks to his deep industry insights and rich management experience. He well understands that in a highly competitive market environment, only through continuous innovation and optimization of services can customer trust and market recognition be gained. Linghu Ping has promoted the establishment of an efficient and professional service system within the company, covering the full-service process from project evaluation and scheme design to financing execution and post-management. The company develops targeted service solutions based on the specific circumstances of different clients, providing one-stop financial services. By fully utilizing its own financial resources and professional advantages, and integrating financial products such as financial leasing, trust, banking, and factoring, the company helps clients achieve their financing goals. Under his leadership, the company has not only successfully expanded its business scope but also significantly improved its service efficiency and quality, winning the favor and praise of many enterprises. In recent years, with the flourishing development of financial technology, Linghu Ping has seized the opportunity to continuously promote innovation and upgrading in the leasing and financing field, laying a solid foundation for the long-term development of the company.

It is particularly worth mentioning that Mr. Linghu Ping is keenly aware of the transformative power of technology in the financial industry. He has a keen insight into the enormous potential of intelligent and digital technologies in the field of financial leasing. For this reason, he personally promoted the company to take the lead in introducing intelligent technology in the industry, leveraging advanced digital technologies such as big data, cloud computing, and artificial intelligence to comprehensively upgrade financial investigation, scheme design, due diligence, and financing management processes. This innovative move not only greatly improves work efficiency and reduces operating costs but also significantly enhances risk prevention and control capabilities, ensuring precise alignment and efficient execution of every financing project. Through the empowerment of intelligent technology, Guizhou Yuyin Leasing Co., Ltd. has achieved innovative breakthroughs in its business model, providing customers with more convenient, efficient, and secure financing experiences. This not only effectively mitigates financial risks but also greatly improves the efficiency and quality of project implementation, injecting strong momentum into the sustainable development of enterprises. Linghu Ping has opened up a new path for the industry through technology leadership and has promoted the overall digital innovation process in the industry.

In the current rational investment and financing trend, digital finance is rapidly changing the operating mode of investment and financing projects like never before. Linghu Ping points that digital financial technology can not only quickly identify and quantify risks but also optimize resource allocation through intelligent analysis, addressing challenges such as information opacity and low decision-making efficiency in traditional investment and financing processes.

Looking ahead, with the continuous progress of financial technology and the continued expansion of application scenarios, the rational investment and financing trends will be further consolidated, and digital finance will help solve financing challenges for more industries and promote high-quality economic development.

(Author: Carol·L·Lu)

Media Contact
Company Name: Global News Online
Contact Person: Media Relations
Email: Send Email
City: NY
Country: United States
Website: www.globalnewsonline.info

Odea Integrations Launches AI-Powered Virtual Assistant, Transforming Customer Experience with Amazon Connect

New AI-powered solutions, including Omni-Agent 360 and advanced IVR, empower SMBs to deliver faster, personalized support with seamless CRM integrations.

Odea Integrations, a leading software development company, is thrilled to announce the expansion of its service portfolio with the launch of its AI-powered Virtual Assistant. This leverages the robust capabilities of Amazon Connect and generative AI to enhance customer interactions and deliver faster, more personalized service while optimizing operational efficiency.

“At Odea Integrations, we believe in transforming customer experience through cutting-edge AI solutions and seamless CRM integrations, giving businesses the tools they need to succeed in today’s digital landscape,” says a company representative.

Customer expectations are higher than ever. Studies show that 73% of customers consider customer experience the deciding factor when choosing when to shop. Additionally, 81% prefer brands that offer personalized service and 72% expect immediate responses when reaching out for support. Many SMBs struggle to meet these expectations due to budget constraints and outdated infrastructure.

Odea’s AI Virtual Assistant offers an affordable and effective solution. It uses advanced AI algorithms to provide agents with contextual responses and instant suggestions, enabling them to solve issues faster and more effectively. The AI Virtual Assistant also includes sentiment analysis and performance evaluation features that empower agents to respond with greater empathy and precision.

Complementing Odea’s AI Virtual Assistant is the Odea Omni-Agent 360, an all-in-one agent desktop solution that integrates Amazon Connect with leading CRM platforms like HubSpot, Salesforce, and Microsoft Dynamics. This unified interface allows agents to manage customer data, communication channels, and interaction histories in one place, eliminating the need to switch between multiple systems. Moreover, Odea goes beyond off-shelf solutions by offering custom CTI solutions aligned with the unique needs of SMBs.

“Our focus is on driving innovation in contact center technology, using AI and cloud-based solutions to help companies optimize their customer service,” added the representative.

In addition to the AI Virtual Assistant and Omni-Agent 360, Odea is innovating in cloud-based IVR (Interactive Voice Response) systems. With AI-powered integration, companies can handle higher call volumes and reduce customer frustration. This creates more efficient customer experiences, higher retention rates, and stronger brand loyalty.

Looking ahead, the company aims to develop a claim-your-number system and other cutting-edge IVR technologies that will further streamline contact center operations for businesses.

Odea Integrations’ expansion into AI-powered solutions marks a transformation in the contact center landscape. With the AI Virtual Assistant, Omni-Agent 360, and AI-enhanced IVR systems, the company is empowering businesses to meet rising customer expectations with greater efficiency and personalization. As it continues to innovate, it remains focused on helping businesses of all sizes stay competitive, offering tailored solutions that streamline operations and enhance customer care.

To learn more about Odea Integrations and its suite of offerings, please visit https://odeaintegrations.com/.

Media Contact
Company Name: Odea Integrations
Contact Person: Team
Email: Send Email
Phone: +1-833-566-9171
Country: United States
Website: https://odeaintegrations.com/